Sort
326,823 grants matching “clinical trial”
Duke Center for HIV Structural Biology
$5,412,818Priyamvada Acharya · Duke University · U54 · FY2024 · AI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
$5,412,341Mirko Paiardini · Emory University · UM1 · FY2022 · AI
Cancer Center Support Grant
$5,410,051Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2010 · CA
Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis
$5,409,374Randall J Bateman · Washington University · R01 · FY2025 · AG
UTMB CLINICAL AND TRANSLATIONAL SCIENCE AWARD
$5,407,519Allan R. Brasier · University Of Texas Med Br Galveston · UL1 · FY2011 · RR
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$5,406,746Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2020 · AI
Targeted Clinical Trial to Reduce the Risk of Antimicrobial Resistance
$5,405,643Victor Yu · University Of Pittsburgh At Pittsburgh · N01 · FY2013 · AI
Molecular Targets Development Program
$5,405,638James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Heart Failure Clinical Research Network Coordinating Center
$5,400,716Kevin J Anstrom · Duke University · U10 · FY2016 · HL
Office of the Clinical Director
$5,400,014Karran Phillips · National Institute On Drug Abuse · ZID · FY2017 · DA
HIV VACCINE TRAILS NETWORK LEADERSHIP GROUP
$5,400,000Fred Hutchinson Cancer Research Center · U01 · FY2005 · AI
PECRB-Research on Type 2 Diabetes Mellitus-Gila River Indian Reservation
$5,400,000National Institute Of Diabetes And Digestive And Kidney Diseases · Y01 · FY2011 · DK
HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUP
$5,400,000Family Health International · U01 · FY2004 · AI
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse
$5,400,000Philip Iredale · Cerevel Therapeutics, Llc · UG3 · FY2021 · DA
Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort
$5,399,026Marilyn S Albert · Johns Hopkins University · U19 · FY2022 · AG
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
$5,397,843Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
PREVENTION OF ALZHEIMER DEMENTIA & COGNITIVE DECLINE
$5,397,013John C S Breitner · University Of Washington · U01 · FY2006 · AG
Convalescent Plasma to Limit Coronavirus Associated Complications: Randomized Blinded Phase 2 Study Comparing Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 Hospitalized Patients
$5,391,810Ralph Lewis Sacco · University Of Miami School Of Medicine · UL1 · FY2020 · TR
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
$5,390,420Duke University · P30 · FY2000 · CA
R-methadone-TAAP/MPAR: an abuse deterrent methadone prodrug with overdose protection: Pre-Clinical Development and Phase 1 Clinical Trial
$5,389,398Lynn Kirkpatrick · Ensysce Biosciences, Inc. · UG3 · FY2019 · DA
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$5,387,719S. Claiborne Johnston · University Of California, San Francisco · UL1 · FY2010 · RR
Hormone-Related Cancers
$5,387,445Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
SPRINT: Signature for Pain Recovery IN Teens
$5,386,781Laura E Simons · Stanford University · R61 · FY2019 · NS
Disease Model Development and Phenotyping Project
$5,384,155Gareth R Howell · Indiana University Indianapolis · U54 · FY2024 · AG
Disease Model Development and Phenotyping Project
$5,384,155Gareth R Howell · Indiana University Indianapolis · U54 · FY2025 · AG